Cargando…

Incidence and Risk Factors of Insulin Resistance Syndrome in 20-59 Year-Old Korean Male Workers

We investigated the incidence of insulin resistance syndrome (IRS) according to the criteria of diagnoses suggested by the American College of Endocrinology/American Association of Clinical Endocrinologists and the risk factors associated with the development of IRS. Among 2,048 subjects without a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo-Geun, Lim, Hyun-Sul, Cheong, Hae-Kwan, Kim, Chong-Soon, Seo, Hyun-Ju
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694631/
https://www.ncbi.nlm.nih.gov/pubmed/18162708
http://dx.doi.org/10.3346/jkms.2007.22.6.968
Descripción
Sumario:We investigated the incidence of insulin resistance syndrome (IRS) according to the criteria of diagnoses suggested by the American College of Endocrinology/American Association of Clinical Endocrinologists and the risk factors associated with the development of IRS. Among 2,048 subjects without a history of/or drug treatment for hypertension, diabetes, dyslipidemia with normal findings at baseline, 1,578 subjects aged 20-59 yr were followed prospectively for 2 yr. The incidence of IRS was 6.9 per 100 persons/year. The relative risk (RR) due to age was 1.03 (95% CI: 1.00-1.05) with every one-year increase in age. The RR associated with an abnormal waist-hip ratio group (≥0.9) was increased by 1.74 (95% CI:1.17-2.58) compared to the normal group (<0.9); RR associated with abnormal alanine transferase was increased (≥35 IU/L) by 1.70 (95% CI: 1.20-2.41) compared to the normal group (<35 IU/L); and the RR associated with abnormal low-density lipoprotein (LDL) cholesterol was increased (≥160 mg/L) by 1.70 (95% CI: 1.19-2.44) compared to the normal LDL cholesterol (<160 mg/L). Lastly, the RR of current smokers was increased by 1.63 (95% CI: 1.09-2.42) compared to that of non-smokers. It is necessary to develop methods of prevention and therapeutic approach to manage the integrated risk factors as opposed to individual factors.